Home > Insider Trading > Filing (0001225208-10-023523)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
885725	Boston Scientific Corp	BSX	Surgical & Medical Instruments & Apparatus (3841)	042695240

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
901458	M Peter Nicholas	One Boston Scientific Place Natick MA 01760-1537		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2010-10-26	50,000	$0.00	9,112,125	No	4	J	Direct
Common Stock	Disposition	2010-10-26	25,000	$6.29	3,681,021	No	4	S	Indirect	By Ltd. Partnership

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	J	Direct
No	4	S	Indirect	By Ltd. Partnership

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Forward Sale Contract (obligation to sell)	Disposition	2010-10-26	50,000	$0.00	50,000	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0	2010-10-26	2010-10-26	No	4	J	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	2,413,088	Indirect	By Trust 2

Footnotes

On October 26, 2010, the reporting person settled a prepaid variable contract originally entered into on October 26, 2009. At the initiation of the contract, the bank paid $363,428.84 to the reporting person.
The forward sale contract obligated the reporting person to deliver to the bank at maturity up to 50,000 shares of the Issuer's common stock depending on market prices at maturity. If the market price per share at maturity was equal to or less than the floor price of $8.5162 per share, the reporting person would deliver 50,000 shares to the bank. If the market price per share at maturity was greater than the floor price, the reporting person would deliver a fewer number of shares. The closing market price per share on October 26, 2010 was $6.29. Accordingly, the reporting person transferred to the bank 50,000 shares of the Issuer's common stock.
Sales reported on this form were transacted pursuant to a 10b5-1 trading plan.
The weighted average sales price reported as stock sales were aggregated for reporting purposes. The per share transaction price ranged from $6.305 to $6.2806. The reporting person will provide, upon request from an appropriate party, the per share sales volumes and prices.
Shares held by a trust of which the reporting persons spouse and brother are trustees and the reporting person's spouse and children are beneficiaries.